OLEMA PHARMACEUTICALS, INC. Contractual Obligation, to be Paid, Year Four
OLEMA PHARMACEUTICALS, INC. (OLMA) had Contractual Obligation, to be Paid, Year Four of $822.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInFourthYear · last filed 2021-11-10
- 2021-09-30: Contractual Obligation, to be Paid, Year Four $822.00K.
- 2021-06-30: Contractual Obligation, to be Paid, Year Four $822.00K.
- 2021-03-31: Contractual Obligation, to be Paid, Year Four $822.00K.
| Period end | Contractual Obligation, to be Paid, Year Four |
|---|---|
| 2021-09-30 | $822.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $822.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $822.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |